本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

TransCode Therapeutics Inc.

9.69
-0.2500-2.52%
盘后9.690.00000.00%17:57 EDT
成交量:1.15万
成交额:11.11万
市值:807.78万
市盈率:-0.02
高:9.90
开:9.64
低:9.38
收:9.94
数据加载中...
2021/08/23

重要事件披露

8-K - Current report
2021/07/21

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/07/13

重要事件披露

8-K - Current report
2021/07/13

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/07/06

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/06

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/02

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/01

SEC问询函

CORRESP [Cover] - Correspondence
2021/05/14

SEC问询函

CORRESP [Cover] - Correspondence
2021/05/06

SEC问询函

CORRESP [Cover] - Correspondence
2021/05/06

SEC问询函

CORRESP [Cover] - Correspondence
2021/05/03

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/04/23

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/23

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/16

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/16

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/04/08

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/03/24

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/03/11

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/26

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933